Our Blog
Caberlin 0.5 mg
Date : 2018-09-14
Caberlin 0.5 mg
Tab Salt Information :
What is Caberlin
0.5 mg?
Caberlin
0.5 mg (Cabergoline) Tablet is used for
Hyperprolactinemic disorders, Moderate to severe labor pain, Moderate to severe
surgery pain and other conditions. Caberlin 0.25 mg Tablet may also be used for
purposes not listed in this medication guide.Caberlin 0.25 mg Tablet contains
Cabergoline as an active ingredient.Caberlin 0.25 mg Tablet works by inhibiting
the effect on pituitary prolactin cells. Sun Pharma manufactures Caberlin 0.25
mg Tablet.Detailed information related to Caberlin 0.25 mg Tablet's uses,
composition, dosage, side effects and reviews is listed below.
Uses of Caberlin
0.5mg Tab :
Cabergoline Can
Help Treat Symptoms Associated With Irregular Menstruation, Unwanted Breast
Milk Production, Infertility, Bone Loss, And Sexual Problems. People With
Pituitary Gland Tumors Also Produce Too Much Prolactin. Cabergoline Is Often
Used To Help Treat This Condition.
Side Effects of
Caberlin 0.5mg Tab :
Decrease In BP,
Dizziness, Vertigo, Headache, Nausea, Sleeplessness, Abdominal Pain, Dyspepsia,
Gastritis, Weakness, Fatigue, Constipation, Vomiting, Breast Pain, Hot Flushes,
Depression, Tingling, Leg Cramps, Raynaud's Syndrome, Psychosis With
Hallucinations, Delusions And Confusion. Potentially Fatal: Risk Of Serotinin
Syndrome With Sibutramine; Avoid Combination.
Drug Interactions
of Caberlin 0.5mg Tab :
Increased Risk Of
Orthostatic Hypotension When Used With Antihypertensives. May Increase
Vasoconstriction Effect Of Dopamine. May Reduce Vasodilation Effect Of
Nitroglycerin. Concurrent Use With SSRIs Or TCAs May Increase The Risk Of
Serotonin Syndrome. Potentially Fatal: Risk Of Serotonin Syndrome With
Sibutramine.
Contraindications
of Caberlin 0.5mg Tab :
Hypersensitivity
To Ergot Derivatives. Uncontrolled Hypertension.
Mechanism of
Action of Caberlin 0.5mg Tab :
Cabergoline Is A
Long-Acting Dopamine D2-Agonist. It Inhibits Prolactin Secretion Through
Hypothalamic Inhibitory Control Exerted Through The Release Of Dopamine.
Absorption: Absorbed From The GI Tract. Undergoes 1st Pass Effect.
Distribution: Plasma Protein Binding: About 40%. Metabolism: Extensively Metabolised
To Inactive Metabolites. Excretion: Mainly Via Faeces.
Special Precautions
for Caberlin 0.5mg Tab :
CV Disease,
Raynaud's Syndrome, Renal Or Hepatic Impairment, Peptic Ulcer, GI Bleeding,
History Of Psychosis, Hypertension. May Affect Ability To Drive Or Operate
Machinery. Pregnancy, Lactation. Prolonged Use And/Or Usage Of High Doses May
Lead To Psychiatric Disorders, Pleural/Retroperitoneal Fibrosis Or Cardiac
Valvular Fibrosis. Monitor Serum Prolactin Level Mthly Until Normalisation.
Monitor Hepatic Function Regularly In Patients With Hepatic Impairment.
Other Products: